Kyntra Bio, Inc. (KYNB)
NASDAQ: KYNB · Real-Time Price · USD
7.34
+0.02 (0.27%)
At close: Apr 20, 2026, 4:00 PM EDT
7.16
-0.18 (-2.45%)
After-hours: Apr 20, 2026, 4:10 PM EDT

Kyntra Bio Revenue

In the year 2025, Kyntra Bio had annual revenue of $6.44M, down -78.26%. Kyntra Bio had revenue of $1.28M in the quarter ending December 31, 2025.

Revenue (ttm)
$6.44M
Revenue Growth
-78.26%
P/S Ratio
4.61
Revenue / Employee
$189,412
Employees
34
Market Cap
29.70M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20256.44M-23.18M-78.26%
Dec 31, 202429.62M-17.18M-36.71%
Dec 31, 202346.80M-93.93M-66.74%
Dec 31, 2022140.73M-94.58M-40.19%
Dec 31, 2021235.31M58.99M33.46%
Dec 31, 2020176.32M-80.26M-31.28%
Dec 31, 2019256.58M43.62M20.48%
Dec 31, 2018212.96M81.96M62.57%
Dec 31, 2017131.00M-52.19M-28.49%
Dec 31, 2016183.19M2.36M1.31%
Dec 31, 2015180.83M43.23M31.41%
Dec 31, 2014137.60M35.43M34.68%
Dec 31, 2013102.17M36.24M54.96%
Dec 31, 201265.93M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Apollomics6.93M
Dyadic International3.09M
Longeveron1.20M
IGC Pharma1.11M
ABVC BioPharma797.92K
Revenue Rankings